Aldeyra Therapeutics SG&A Expense (Quarterly) Trends

Aldeyra Therapeutics Inc (ALDX)

4.21 +0.01 (+0.24%) USD | NASDAQ | May 02, 16:00

4.215 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	1.800M
September 30, 2023	2.589M
June 30, 2023	3.380M
March 31, 2023	5.567M
December 31, 2022	4.735M
September 30, 2022	3.245M
June 30, 2022	3.144M
March 31, 2022	4.249M
December 31, 2021	2.563M
September 30, 2021	2.547M
June 30, 2021	3.069M
March 31, 2021	3.105M
December 31, 2020	2.505M
September 30, 2020	2.256M
June 30, 2020	2.22M
March 31, 2020	3.005M
December 31, 2019	3.214M
September 30, 2019	2.839M
June 30, 2019	3.116M
March 31, 2019	2.985M
December 31, 2018	2.546M
September 30, 2018	3.066M
June 30, 2018	2.373M

Date	Value
March 31, 2018	1.891M
December 31, 2017	1.501M
September 30, 2017	1.476M
June 30, 2017	1.482M
March 31, 2017	1.727M
December 31, 2016	1.206M
September 30, 2016	1.397M
June 30, 2016	1.462M
March 31, 2016	1.456M
December 31, 2015	1.226M
September 30, 2015	1.261M
June 30, 2015	0.9549M
March 31, 2015	0.9721M
December 31, 2014	1.007M
September 30, 2014	0.7725M
June 30, 2014	0.9826M
March 31, 2014	0.8006M
December 31, 2013	0.8324M
September 30, 2013	0.5004M
June 30, 2013	0.6606M
March 31, 2013	0.1413M
December 31, 2012	0.0203M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.800M

Minimum

Dec 2023

5.567M

Maximum

Mar 2023

3.113M

Average

3.069M

Median

Jun 2021

SG&A Expense (Quarterly) Benchmarks